Elon Musk’s Neuralink has successfully raised $280 million in a recent funding cycle. The chip implants startup, which lets users control their mobile and computer devices through their brains, recently received an approval for human clinical trials. The startup is able to install chip implants as small as 4 to 6 μm in width and has already passed its tests on animals.
Neuralink’s Previous Years Fundings
The startup led by Elon Musk got considerable attention from investors who were working on similar technologies. Neuralink raised $518.9 million in 2021 and $278.1 million last year, numbers that look optimistic considering the ambitious future lies ahead for it.
What is Neuralink?
Neuralink, purchased by Elon Musk in 2016, is developing brain–computer interfaces (BCIs), a “sewing machine-like” device that can let users control computers with brains. Musk hires expert neuroscientists, biochemists and other engineers to develop human enhancements in the long run.